<p>Part A: Introduction<br>1. Introduction to Catha edulis and Cannabis<br>2. Ethnomedicinal uses of cannabis<br>3. Ethnomedicinal uses of Catha edulis<br>4. Cannabis chemotypes: sativa, indica, and others<br>5. Cannabinoids and their subclasses – Lucia Kabanga<br>6. The Chemistry and Pharmacology of Tetrahydrocannabinol and Cannabidiol<br>7. Cannabis infused foods: Efficacy, safety and regulation<br>8. Water resource demands and management in the growth of cannabis industrialization<br><br>Part B: Chemical analyses and bioassays<br>1. Extraction and isolation of cannabinoids<br>2. Chromatographic fingerprinting and spectroscopic profiling of cannabinoids<br>3. Antiviral properties of cannabidiol (CBD)<br>4. In vitro and in vivo assays and safety profiles of cannabinoids<br>5. In vitro and in vivo toxicology of cannabinoids<br>6. Immunomodulatory properties of cannabis<br>7. Pharmacologically active ingredients from Catha edulis<br>8. Phytochemistry of Catha edulis<br>9. In vitro and in vivo assays and toxicity profile of Catha edulis<br>10. Physicochemical properties of Catha edulis<br>11. Cannabis and reproductive physiology<br><br>Part C: Medicinal Chemistry, Chemical Biology and Pharmacology<br>1. Cannabinergics<br>2. Medicinal Chemistry of cannabinoids and endocannabinoids<br>3. Biosynthesis of cannabinoids and endocannabinoids<br>4. Cannabinoid ligands and receptors<br>5. Medicinal Chemistry of selected active compounds in Catha edulis<br>6. Catha edulis, Cannabis and the nervous system<br>7. Structural analysis of Catha edulis’s sympathomimetric amines to amphetamine and adrenaline<br>8. Stimulants from Catha edulis<br>9. Catha edulis and concomitant drug bioavailability<br>10. Interactions of Catha edulis agents with CB2 receptors<br>11. In Silico Drug Design Studies of Bioactives in Catha edulis, Cannabis, and their derivative<br><br>Part D: Catha edulis and cannabinoids in disease management; Clinical aspects Prologue to part D 1. Cannabis in pain management<br>2. Cannabinoids in cancer management<br>3. Cannabis in antimicrobial drug development<br>4. Cannabis in fungal infection management<br>5. Cannabis in Post-traumatic stress disorder management<br>6. Cannabis use in Unani Medicinal practices<br>7. Catha edulis in antimicrobial drug development<br>8. Dependence syndrome in Catha edulis product uses<br>9. Catha edulis in pain management<br>10. Catha edulis and type 2 diabetes mellitus<br>11. Catha edulis in the management of cancers<br>12. Clinical uses of cannabis and Catha edulis products<br>13. Cannabinoid therapy and concomitant administered agents<br>14. Dependence syndrome in cannabis product uses<br>15. Hepatocellular injury from Catha edulis<br>16. Innovative cannabis products on the market<br>17. Pestcides and disease causing contaminants in Khat and khat products<br><br>Part E: Policy and regulations<br>1. Industrial and medical use approvals and regulations of Cannabis products<br>2. Conservation of Cannabis species and their products<br>3. Policy and Regulation of Catha edulis product uses<br>4. Future perspectives on the use of cannabis and Catha edulis products</p>
